Filing Details
- Accession Number:
- 0001209191-18-037605
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-13 20:00:05
- Reporting Period:
- 2018-06-12
- Accepted Time:
- 2018-06-13 20:00:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1609320 | Werner Kroll | 12544 High Bluff Drive, Suite 200 San Diego CA 92130 | Svp, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-06-12 | 2,500 | $66.16 | 16,005 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The weighted average sale price for these transactions was $66.1568 per share, with a range of $66.15 to $66.18. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
